ArticleAmerican journal of ophthalmology case reports2025
Novel use of plasma pen ablation for the treatment of extensive periocular xanthogranuloma: A case report.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This case demonstrates a novel technique for treatment of periocular xanthogranuloma using plasma pen ablation, a non-invasive therapy that stimulates skin regeneration. It is used in various conditions, such as benign skin growth removal and non-surgical blepharoplasty, but, to our knowledge, this is the first reported case of periocular xanthogranuloma treated with this method. Observations: A 45-year-old male with dyslipidemia presented with bilateral extensive periocular xanthogranuloma slowly progressing over 10 years, resistant to steroid injection and bleomycin, with positive Touton giant cells on biopsy. The patient underwent 2 procedures, 1 year apart, involving partial excision to achieve 1.5 mm lesion thickness followed by plasma pen ablation with an acupuncture tip. A 12-month and 6-month follow-up after the first and second procedures, respectively, showed effective cosmetic and functional improvement, minimal recurrence, and no notable complications. Conclusion and importance: Due to the extensive and irregular distribution of the lesions, traditional full-thickness excision and skin grafting was not feasible in all affected areas. Thus, a plasma pen was utilized. Plasma pen ablation offers a promising new approach in the management of extensive periocular and primary simple xanthogranuloma. Further research is encouraged to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.